Drug shows promise in 1st largely minority COVID-19 study A drug company said Friday that a medicine it sells to tamp down inflammation has helped prevent the need for breathing machines in hospitalized COVID-19 patients in the first large study that... AP NEWS

A drug company said Friday that a medicine it sells to tamp down inflammation has helped prevent the need for breathing machines in hospitalized COVID-19 patients in the first large study that primarily enrolled Hispanics and Blacks.

CDC reverses controversial coronavirus guidance that said people without symptoms may not need a test The new guidance says that people without symptoms who have been in close contact with an infected person "need a test." Will Feuer CNBC

The Centers for Disease Control and Prevention on Friday reversed controversial coronavirus testing guidance that said people who were exposed to an infected person but weren’t showing any symptoms did “not necessarily need a test.”

2020.09.10 Harvard Medical Grand Rounds

Dr. Fauci discussion, with slides,  on the backround of the coronavirus, with Harvard Medical School panel.

Blood donations show the U.S. is still nowhere near herd immunity Testing donated blood for antibodies to the coronavirus highlights that the vast majority of the United States remains susceptible to infection. Helen Thompson Science News

To better understand how widely the coronavirus has spread in the United States, some researchers are turning to an unusual source of data: blood donations.

Report: Much needs doing to shield nursing homes from virus WASHINGTON (AP) — The Trump administration is claiming “resounding vindication” from an independent commission's report on the coronavirus crisis in nursing homes, but some panel members say... AP NEWS

WASHINGTON (AP) — The Trump administration is claiming “resounding vindication” from an independent commission’s report on the coronavirus crisis in nursing homes, but some panel members say that’s a misinterpretation of their conclusion that much remains to be done to safeguard vulnerable residents.

Two drug companies that are leading the race to develop coronavirus vaccines bowed to public pressure on Thursday, abandoning their traditional secrecy and releasing comprehensive road maps of how they are evaluating their vaccines.

The companies, Moderna and Pfizer, revealed details about how participants are being selected and monitored, the conditions under which the trials could be stopped early if there were problems, and the evidence researchers will use to determine whether people who got the vaccines were protected from Covid-19.

Moderna’s study will involve 30,000 participants, and Pfizer’s 44,000.

WHO Europe chief urges nations to keep up virus quarantines GENEVA (AP) — The World Health Organization’s European director warned national governments Thursday against reducing the quarantine period for people potentially exposed to the coronavirus, even... AP NEWS

GENEVA (AP) — The World Health Organization’s European director warned national governments Thursday against reducing the quarantine period for people potentially exposed to the coronavirus, even as he acknowledged that COVID-19 “fatigue” was setting in with growing public resistance to the measures needed to control the pandemic.

At the beginning of the coronavirus pandemic, there were lots of stories about scrappy manufacturers promising to revamp their factories to start making personal protective equipment in the U.S.

Back in the spring, fuel-cell maker Adaptive Energy retooled part of its factory in Ann Arbor, Mich., to make plastic face shields. Now, 100,000 finished shields are piling up in cardboard boxes on the factory floor — unsold.

"We jumped in head first," said Ranvir Gujral, the company's principal owner. He added ruefully: "We weren't the only ones with a brilliant idea of getting our folks back to work and trying to help and manufacture PPE."